Author

Darcie J. Radel

Observed names: D.J. Radel, Darci Radel, Darcie Radel

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5081205035

Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease

2017 · Allan B. Dietz, Eric J. Dozois, et al. · Gastroenterology · 195

High‐Resolution Molecular Validation of Self‐Renewal and Spontaneous Differentiation in Clinical‐Grade Adipose‐Tissue Derived Human Mesenchymal Stem Cells

2014 · Amel Dudakovic, Emily Camilleri, et al. · Journal of Cellular Biochemistry · 162

Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections

2019 · Harold M. Burkhart, Muhammad Yasir Qureshi, et al. · Journal of Thoracic and Cardiovascular Surgery · 61

Safety Studies for Use of Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells in a Rabbit Model for Osteoarthritis to Support a Phase I Clinical Trial

2016 · Scott M. Riester, Janet M. Denbeigh, et al. · Stem Cells Translational Medicine · 40

Closure of a Recurrent Bronchopleural Fistula Using a Matrix Seeded With Patient-Derived Mesenchymal Stem Cells

2016 · Johnathon M. Aho, Allan B. Dietz, et al. · Stem Cells Translational Medicine · 40

A combined flow cytometry–based method for fetomaternal hemorrhage and maternal D

2008 · Darcie J. Radel, Connie S. Penz, et al. · Transfusion · 15

Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome

2017 · Muhammad Y. Qureshi, Allison K. Cabalka, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 10

Management of externally manufactured cell therapy products: the Mayo Clinic approach

2021 · Timothy D. Wiltshire, Michael C. Deeds, et al. · Cytotherapy · 5

Comparison of two automated cell counters for enumeration and viability of mesenchymal stem cells for clinical cellular therapy trials

2018 · D.J. Radel, P. Madde, et al. · Cytotherapy · 3

A consistent, and predictable drug: The first 100 patients treated with autologous adipose derived mesenchymal stromal cells (MSCs) at the Mayo Clinic

2017 · A. Dietz, A. van Wijnen, et al. · Cytotherapy · 1

Computer-based assessment of surveillance and therapy for microalbuminuria in diabetes mellitus

1996 · Robert H. Noth, Darcie J. Radel, et al. · Journal of Investigative Medicine · 1

How do I create a cost structure for cellular therapy laboratory services supporting clinical trials?

2026 · Monica S. Klein, Darcie J. Radel, et al. · Transfusion

Process Development and Manufacturing: MANAGING EXPANSION OF A MAJOR ACADEMIC BIOMANUFACTURING FACILITY

2022 · E.J. Gilles, D.J. Radel, et al. · Cytotherapy

Mesenchymal Stem/Stromal Cells: AUTOLOGOUS, CULTURE-EXPANDED, ADIPOSE-DERIVED MESENCHYMAL STROMAL CELL THERAPY FOR OSTEOARTHRITIS; PHASE I MANUFACTURING EXPERIENCE

2022 · J. Murphy, A. Krych, et al. · Cytotherapy

A manufacturing platform for adipose derived mesenchymal stromal cells (AdMSC) supporting clinical trials for diverse indications

2015 · Darcie J. Radel, Greg W. Butler, et al. · Cytotherapy

Works count: 15

Citation count: 533

H-index: 7

I10-index: 7